| Accord Healthcare AG - Ondansetron Accord 8 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 66785 | | 02 | | Ondansetron Accord 8 mg/4 ml | | Konzentrat zur Herstellung einer Infusionslösung | | A04AA01 | | Ondansetron | | 07.12.2018 | | |
|
| Composition |
| ondansetronum 8 mg ut ondansetroni hydrochloridum dihydricum, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile, q.s. ad solutionem pro 4 ml corresp. natrium 14.53 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Ondansetron | 8mg / 4ml |
| | BAG: Active Agent | Dose |
|---|
| Ondansetron | 8 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Acidum Hydrochloridum | | Sodium Chloride | | Natrii Citras Dihydricus | | Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 5 | 57.55 | 79.00 | B | SL | Yes |
|
